EGFR and neoplasm: Haura EB et al. reported that the lowest tumor concentration detected in operative tumor was 3.638 μM12, which was much higher than gefitinib IC50 for growth in cell lines with EGFR sensitive mutations (gefitinib IC50 for H3255 cell lines = 0.04 μM)13.